Effect of the non-specific matrix metalloproteinase inhibitor Doxycycline on endometriotic implants in an experimental rat model

  • Authors:
    • Umit Goktolga
    • Sabri Cavkaytar
    • Sadiman Kiykac Altinbas
    • Omer Lutfi Tapisiz
    • Anil Tapisiz
    • Ozlem Erdem
  • View Affiliations

  • Published online on: February 19, 2015     https://doi.org/10.3892/etm.2015.2304
  • Pages: 1813-1818
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of this study was to investigate the possible therapeutic effects of Doxycycline (Dox) on endometriotic lesions in an experimental rat model. Thirty‑seven female Wistar albino rats with surgically induced endometriosis were randomized and divided into four groups. The rats were administered 5 mg/kg/day oral Dox in Group 1 (low‑dose Dox group, n=9), 20 mg/kg/day oral Dox in Group 2 (high‑dose Dox group, n=10) and 1 mg/kg single dose, subcutaneous leuprolide acetate in Group 3 (leuprolide acetate group, n=9). The rats in Group 4 (control group, n=9) were given no medication. The rats received medication for three weeks and were then sacrificed to evaluate the morphological and histological features of the implants. Matrix metalloproteinase (MMP)‑9 immunoreactivity of the implants was also evaluated. The size of the endometriotic implants decreased in Groups 1‑3 but statistically significant differences were not observed among the groups. The mean surface area of the endometriotic implants decreased from 69.3±30.8 to 52.1±27.0 mm² in Group 1 (P>0.05), from 60.2±18.9 to 38.6±28.7 mm² in Group 2 (P>0.05) and from 58.1±33.1 to 26±9.0 mm² in Group 3 (P=0.03). The epithelial MMP‑9 immunohistochemical score was significantly higher in Group 1 and lower in Group 3 when compared with the control group (Group 4) (P=0.042 and P=0.014, respectively). When the stromal MMP‑9 immunohistochemical and histopathological scores of the endometriotic implants were compared, no statistically significant differences were found among the groups. Although there was no statistically signifi­cant difference, Dox reduced the endometriotic implant area in the rat endometriosis model. Further studies are required to investigate the potential efficacy of Dox in endometriosis due to its widespread use and tolerability.
View Figures
View References

Related Articles

Journal Cover

May-2015
Volume 9 Issue 5

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Goktolga U, Cavkaytar S, Altinbas SK, Tapisiz OL, Tapisiz A and Erdem O: Effect of the non-specific matrix metalloproteinase inhibitor Doxycycline on endometriotic implants in an experimental rat model. Exp Ther Med 9: 1813-1818, 2015.
APA
Goktolga, U., Cavkaytar, S., Altinbas, S.K., Tapisiz, O.L., Tapisiz, A., & Erdem, O. (2015). Effect of the non-specific matrix metalloproteinase inhibitor Doxycycline on endometriotic implants in an experimental rat model. Experimental and Therapeutic Medicine, 9, 1813-1818. https://doi.org/10.3892/etm.2015.2304
MLA
Goktolga, U., Cavkaytar, S., Altinbas, S. K., Tapisiz, O. L., Tapisiz, A., Erdem, O."Effect of the non-specific matrix metalloproteinase inhibitor Doxycycline on endometriotic implants in an experimental rat model". Experimental and Therapeutic Medicine 9.5 (2015): 1813-1818.
Chicago
Goktolga, U., Cavkaytar, S., Altinbas, S. K., Tapisiz, O. L., Tapisiz, A., Erdem, O."Effect of the non-specific matrix metalloproteinase inhibitor Doxycycline on endometriotic implants in an experimental rat model". Experimental and Therapeutic Medicine 9, no. 5 (2015): 1813-1818. https://doi.org/10.3892/etm.2015.2304